BRIEF published on 11/26/2024 at 00:25, 1 year ago NexgenRx Reports Q3 Growth and Announces Dividend Financial Results Revenue Increase Dividend Declaration SaaS Solutions EBITDA Growth
BRIEF published on 11/26/2024 at 00:25, 1 year ago NexgenRx annonce une croissance au troisième trimestre et un dividende Résultats Financiers Solutions SaaS Augmentation Des Revenus Croissance De L'EBITDA Déclaration De Dividendes
PRESS RELEASE published on 11/26/2024 at 00:20, 1 year ago NexgenRx Announces Third Quarter Results and Declaration of Divdend NexgenRx announces Q3 2024 financial results, with quarterly revenue up to $4,158,667 and increased positive EBITDA of $446,448. A dividend of $0.005 per share declared for shareholders Financial Results Revenue Dividend Q3 2024 NexgenRx
BRIEF published on 10/07/2024 at 23:35, 1 year 1 month ago NexgenRx Re-Appoints Charles Burns to Board of Directors Technology Solutions Board Appointment Canada NexgenRx Charles Burns
BRIEF published on 10/07/2024 at 23:35, 1 year 1 month ago NexgenRx reconduit Charles Burns au sein de son conseil d'administration Canada Nomination Au Conseil D'administration Solutions Technologiques NexgenRx Charles Burns
PRESS RELEASE published on 10/07/2024 at 23:30, 1 year 1 month ago NexgenRx Announces Director Re-Appointment NexgenRx Inc. announces re-appointment of Charles Burns to its Board of Directors. Company provides full-service Third-Party Administrator & Technology Solutions in Canada Board Of Directors Technology Solutions Third-party Administrator NexgenRx Inc. Charles Burns
BRIEF published on 10/01/2024 at 14:05, 1 year 2 months ago NexgenRx Appoints Linda Brennan to Board of Directors Board Of Directors Corporate Governance Appointment NexgenRx Linda Brennan
BRIEF published on 10/01/2024 at 14:05, 1 year 2 months ago NexgenRx nomme Linda Brennan au conseil d'administration Conseil D'administration Gouvernance D'Entreprise Rendez-vous NexgenRx Linda Brennan
PRESS RELEASE published on 10/01/2024 at 14:00, 1 year 2 months ago NexgenRx Announces New Director NexgenRx announces the appointment of Linda Brennan as a new member to its Board of Directors. Linda brings expertise in finance and corporate governance to the company Board Of Directors Appointment Finance NexgenRx Linda Brennan
BRIEF published on 07/18/2024 at 20:05, 1 year 4 months ago NexgenRx Announces Share Issuances Under Consulting Agreement Consulting Agreement Share Issuance NexgenRx PBM Management Services SaaS Model
Published on 12/05/2025 at 02:35, 9 hours 38 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 11 hours 13 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 13 hours 8 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 13 hours 13 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 12:05, 8 minutes ago Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 13 minutes ago CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 13 minutes ago Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million
Published on 12/05/2025 at 11:08, 1 hour 4 minutes ago Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 12/05/2025 at 08:45, 3 hours 28 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 3 hours 28 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 3 hours 31 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 17 hours 58 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 18 hours 13 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
